AVIR Operating Expenses

Atea Pharmaceuticals Inc · Operating Expenses

AVIR logo

AVIR Operating Expenses

Latest reported$35.10M
AVIR Quarterly Operating Expenses ($2.37M → $35.10M)
High-resolution chart · PNG

AVIR operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
35,099,000
47,904,000
54,934,000
7,333,000
38,926,000
35,601,000
38,922,000
17,279,000
46,812,000
69,702,000
46,469,000
22,726,000
19,099,000
12,615,000
25,181,000
16,281,000
32,295,000
12,542,000
13,188,000
11,939,000
11,901,000
8,759,000
14,140,000
4,028,000
2,248,000
4,041,000
4,745,000
3,769,000
3,718,000
2,372,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.